Testimonial: Retina Detachment (Mr. Ken Tai) Follow me on YouTube and Facebook for more updates and information! Contact Evelyn @ +65 8699 5092 Facebook: Purtier - Live Stem Cell Therapy. By: PurtierSG … Continue reading →

Javascript is currently disabled in your web browser. For full site functionality, it is necessary to enable Javascript. In order to enable it, please see these instructions. 6 hours ago Georgia Tech/Emory University Associate Professor Todd McDevitt and graduate student Anh Nguyen make microparticles to be used for delivering growth factors to stem cells. Credit: Rob Felt Before scientists and engineers can realize the dream of using stem cells to create replacements for worn out organs and battle damaged body parts, they'll have to develop ways to grow complex three-dimensional structures in large volumes and at costs that won't bankrupt health care systems. Researchers are now reporting advances in these areas by using gelatin-based microparticles to deliver growth factors to specific areas of embryoid bodies, aggregates of differentiating stem cells. The localized delivery technique provides spatial control of cell differentiation within the cultures, potentially enabling the creation of complex three-dimensional tissues. The local control also dramatically reduces the amount of growth factor required, an important cost consideration for manufacturing stem cells for therapeutic applications. The microparticle technique, which was demonstrated in pluripotent mouse embryonic cells, also offers better control over the kinetics of cell differentiation by delivering molecules that can … Continue reading →

Freeport, The Bahamas (PRWEB) July 09, 2013 Okyanos Heart Institute, whose mission it is to bring a new standard of care and better quality of life to patients with coronary artery disease using cardiac stem cell therapy, has announced that Antonio Colombo, M.D., F.A.C.C. has joined the esteemed group of Okyanos medical advisory council members. Dr. Colombo is director of the Cardiac Catheterization Laboratory at Columbus Hospital and chief of invasive cardiology at San Raffaele Hospital, both in Milan, Italy, and is a visiting professor of medicine at Columbia Medical Center in New York, USA. Dr. Colombo is a pioneer of the coronary stent placement concept, and he helped define the role of intravascular ultrasound in stent placement. In addition, he was the principal investigator for a cardiac stem cell therapy trial at San Raffaele Hospital, which treated patients with chronic angina. Okyanos Chief Medical Officer Howard T. Walpole Jr. stated, Dr. Colombo is a leading innovator in cardiology. I welcome his contribution to Okyanos Heart Institutes goal of providing patients the highest standard of safety and care possible with the Okyanos treatment. The use of adult stem cells derived from adipose (fat) tissue to treat coronary artery disease is … Continue reading →

By Denver Post Editorial Board Medical advances come so fast and furious these days, it might be easy to lose perspective as to how transformative these discoveries can be. Limb and even face transplants are possible, as is tissue regeneration. And joint replacement well, that has become almost routine. Against this backdrop, it's understandable to perhaps have overlooked an announcement last week that researchers found no detectable HIV virus levels in two stem-cell transplant patients who had previously tested positive for HIV. It's too early to use the word "cure," but the implications are breath-taking. At the very least, the findings could be an important stepping stone on the path to a cure for a virus that has led to more than 30 million deaths worldwide. The life-changing potential of the discovery brings to mind the need for federal lawmakers to pass legislation cementing into law the Obama administration's rules on embryonic stem-cell research. As it stands, these sensible rules could be modified by a successive administration. U.S. Rep. Diana DeGette, D-Colo., reintroduced such a measure several weeks ago, and we hope it passes. Congress passed similar measures twice before, but they were vetoed by then-President George W. Bush. To … Continue reading →

Purtier NZ Live Stem Cell Therapy presented by Dr Chen For Live demo and discussion: Call John 90036287 / Daphne 91455217. By: petty joy … Continue reading →

by Buena Bernal Posted on 07/06/2013 9:06 PM |Updated 07/08/2013 2:15 PM DOH ON STEM CELL. (Left) Health Secretary Enrique Ona and (right) FDA Director Kenneth Hartigan-Go talks to Rappler about stem cell therapy. Photos by Rappler/Naoki Mengua MANILA, Philippines (UPDATED) Rappler talked to Department of Health (DOH) Secretary Enrique Ona and Food and Drug Administration (FDA) Director Kenneth Hartigan-Go to clarify the governments stance on stem cell therapy. Stem cell therapy or regenerative medicine is a medical intervention that uses the bodys repair cells to substitute old cells. It is done for medical and aesthetic purposes that are still being investigated, according to the health secretary. Asked why the treatment was allowed in the market despite no definitive curative and preventive benefits, FDA's Hartigan-Go said authorities never allowed the treatment to begin with. Its just there. Now, the DOH under Secretary Ona's leadership took action," he said. (READ: DOH: Stem cell therapy not yet proven to be curative) On March 18, the DOH issued the rules and regulations for the accreditation of health facilities engaging in human stem cell and cell-based or cellular therapies in the Philippines. The FDA has also released a circular on Monday, Jully 8, regarding … Continue reading →

NEW YORK, July 08, 2013 (eTeligis via ACCESSWIRE) -- IntelliCell BioSciences, Inc. (SVFC), a developer of novel, patented technology used to isolate stromal vascular fraction cells (stem cells) from adipose (fat) tissue. These cells are used to address the regenerative, curative and preventative conditions of disease, announced New York based Maxim Group has issued a research opinion on stem cell sector, and our position within the industry. Jason Kolbert, the research analyst at Maxim Group commented in his report, IntelliCells position on the legal/regulatory status of SVFC (stromal vascular fraction cells) is that the product is a human cell, tissue, and cellular and tissue-based product (HCT/Ps) and is regulated under the regulations created under 21 C.F.R. 1271. The Company maintains that the SVFC product falls within the exemption from FDA regulation found under 21 C.F.R. 1271.15(b). This is because the HCT/Ps are removed from and reintroduced into the same patient during the same surgical procedure as that term is used in the practice of medicine. The cells that are reintroduced are exactly the same cells (i.e., such cells) as the cells removed from the autologous patient. Thus, the SVFC product falls under an exemption to FDA regulation. Alternatively, even if … Continue reading →

Home Mail News Sports Finance Weather Games Groups Answers Flickr More omg! Shine Movies Music TV Health Shopping Travel Autos Homes Search News Search Web Sign In Mail Help Account Info Help Suggestions Yahoo! Home Video Photos GMA Year in Review LiveRoom Odd Comics Travel Opinion Trending Now Who Knew? Weather The Upbeat U.S. U.S. Video GMA Education Religion Crimes and Trials The Lookout Local Contributor Network Year In Review World World Video Middle East Europe Latin America Africa Asia Canada Australia/Antarctica Business Video Exclusives Today's Markets Stocks Personal Finance Marketplace Entertainment Video Clinton Concert Celebrity TV Movies Music Fashion Books Arts Theater Dear Abby Comics Odd News Sports Video NFL MLB NBA NCAAF NCAAB Soccer Cycling NHL Tennis Golf Boxing Motor Sports MMA Olympics Tech Gadgets Wireless Apple Social Media Security Open Source Gaming Apps This Could Be Big Upgrade Your Life Politics Remake America The Issues Women and Politics Press Releases Video Science Science Video Weather News Space / Astronomy Pets Dinosaurs / Fossils Biotech Energy Green Health Video Weight Loss Cancer Sexual Health Medications/Drugs Parenting/Kids Seniors/Aging Diseases/Conditions Blogs The Lookout The Sideshow Around the World Katie's Take Power Players This Could Be Big Newsmakers Trending Now Just … Continue reading →